Literature DB >> 18408260

Medpor regulates osteoblast's microRNAs.

Annalisa Palmieri1, Furio Pezzetti, Giorgio Brunelli, Marcella Martinelli, Luca Scapoli, Marzia Arlotti, Elena Masiero, Francesco Carinci.   

Abstract

Porous polyethylene (PP or Medpor) is an alloplastic material worldwide used for craniofacial reconstruction. Although several clinical studies are available, there is a lack as regard the genetic effects. Because PP is always fixed on bone and the mechanism by which PP acts on osteoblasts is unknown, we therefore attempted to address this question by using microRNA microarray techniques to investigate the translation regulation in osteoblasts exposed to PP. The miRNA oligonucleotide microarray provides a novel method to carry out genome-wide microRNA profiling in human samples. By using miRNA microarrays containing 329 probe designed from Human miRNA sequence, we identified in osteoblast-like cells line (MG-63) cultured with Medpor (Porex Corporation, Fairburn, Georgia, USA) several miRNA which expression is significantly modified. We identified 16 up-regulated miRNA (i.e. mir-337, mir-515-3p, mir-377, mir-153, mir-367, mir-152, let-7b, mir-92, mir-155, mir-424, mir-148b, mir-368, mir-18b, mir-520d, mir-20b, mir-128a) and 2 down-regulated miRNA (i.e. mir-143, mir-32). The data reported are, to our knowledge, the first study on translation regulation in osteoblasts exposed to PP. They can be relevant to better understand the molecular mechanism of bone regeneration and as a model for comparing other materials with similar clinical effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408260

Source DB:  PubMed          Journal:  Biomed Mater Eng        ISSN: 0959-2989            Impact factor:   1.300


  10 in total

1.  Applications of biomaterials for bone augmentation of jaws: clinical outcomes and in vitro studies.

Authors:  L Tettamanti; M Andreasi Bassi; G Trapella; V Candotto; A Tagliabue
Journal:  Oral Implantol (Rome)       Date:  2017-04-10

Review 2.  microRNA Regulation of Skeletal Development.

Authors:  Steven R Sera; Nicole I Zur Nieden
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

Review 3.  Global gene expression analysis for evaluation and design of biomaterials.

Authors:  Nobutaka Hanagata; Taro Takemura; Takashi Minowa
Journal:  Sci Technol Adv Mater       Date:  2010-02-22       Impact factor: 8.090

Review 4.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

5.  MicroRNA-17-92 cluster regulates osteoblast proliferation and differentiation.

Authors:  Mingliang Zhou; Junrong Ma; Shiju Chen; Xiang Chen; Xijie Yu
Journal:  Endocrine       Date:  2013-05-15       Impact factor: 3.633

6.  Manipulation of miRNA activity accelerates osteogenic differentiation of hMSCs in engineered 3D scaffolds.

Authors:  Peter D Mariner; Erika Johannesen; Kristi S Anseth
Journal:  J Tissue Eng Regen Med       Date:  2011-06-27       Impact factor: 3.963

Review 7.  The microRNA-148/152 family: multi-faceted players.

Authors:  Yue Chen; Yong-Xi Song; Zhen-Ning Wang
Journal:  Mol Cancer       Date:  2013-05-19       Impact factor: 27.401

8.  The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease.

Authors:  L Elia; M Quintavalle; J Zhang; R Contu; L Cossu; M V G Latronico; K L Peterson; C Indolfi; D Catalucci; J Chen; S A Courtneidge; G Condorelli
Journal:  Cell Death Differ       Date:  2009-10-09       Impact factor: 15.828

9.  Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells.

Authors:  Angela Schoolmeesters; Teresa Eklund; Devin Leake; Annaleen Vermeulen; Queta Smith; Shelley Force Aldred; Yuriy Fedorov
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240

10.  Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patients.

Authors:  Rui Zhang; Shangen Zheng; Yuwen Du; Yuanyuan Wang; Wenqiao Zang; Guoqiang Zhao
Journal:  Diagn Pathol       Date:  2014-03-18       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.